What Is Phytosphingosine? An Antimicrobial Sphingolipid and Ceramide Precursor's Science Guide
What Is Phytosphingosine? An Antimicrobial Sphingolipid and Ceramide Precursor's Science Guide
Key Scientific Facts
- Belongs to the sphingoid base class — serves a dual role as both an antimicrobial agent and a ceramide precursor
- C18-phytosphingosine (t18:0) is the dominant natural sphingoid base form in human skin
- Inhibits Staphylococcus aureus and Candida albicans at clinical concentrations
- In atopic dermatitis, phytosphingosine deficiency is directly linked to ceramide AP (acylphytosphingosine) deficiency
- A dual benefit for acne-prone skin: sebaceous-duct pathogen control + barrier repair
- CIRÈLL's TriBarrier System adds an additional antimicrobial defense layer to the lipid matrix with phytosphingosine
Expert Support for Your Skin Barrier
Reach our expert team directly with your questions about phytosphingosine and the CIRÈLL TriBarrier System.
Contact Us on WhatsAppContents
- The Sphingolipid Family: An Overview
- Chemical Structure: Sphingoid Base Classes
- The Antimicrobial Mechanism: Membrane Disruption
- The Ceramide Precursor Role: The Biosynthesis Pathway
- Atopic Dermatitis and Phytosphingosine Deficiency
- A Dual Benefit for Acne-Prone Skin
- Suitable Skin Types and Conditions
- The Importance of the Ceramide Combination
- A Concentration and Efficacy Table
- A Daily Usage Protocol
- Conclusion: Phytosphingosine in CIRÈLL's TriBarrier
Phytosphingosine is a sphingolipid naturally present in human skin. With its anti-inflammatory and antimicrobial properties, it both balances the skin microbiota and serves as a precursor substance for ceramide synthesis.
The Sphingolipid Family: An Overview
Sphingolipids are a lipid class that forms the core structural components of cell membranes and plays critical roles in biological signal transduction. In human skin, sphingolipids make up roughly 50% of the stratum corneum lipid matrix and are indispensable for barrier function.
| Sphingolipid Class | Structural Feature | Function in Skin | Barrier Role |
|---|---|---|---|
| Ceramides | Sphingoid base + fatty acid | Lipid matrix formation, barrier homeostasis | The primary barrier lipid |
| Sphingomyelins | Sphingoid base + phosphorylcholine | Cell membrane structure, signal transduction | An indirect barrier contribution |
| Glycosphingolipids | Sphingoid base + sugar | Cell-surface recognition, anti-inflammatory | Barrier signaling |
| Sphingoid Bases | A free long-chain amino alcohol | Antimicrobial, ceramide precursor, apoptosis | Defense + repair |
| Sphingosine (d18:1) | C18, two OH groups, a trans-4 double bond | Antimicrobial, keratinocyte differentiation | Surface defense |
| Phytosphingosine (t18:0) | C18, three OH groups, saturated | Strong antimicrobial, a ceramide-P precursor | Strong defense + repair |
"What makes phytosphingosine distinct among sphingoid bases is that it carries three hydroxyl groups (a t18:0 configuration). This chemical property both increases its antimicrobial activity and gives it ideal substrate properties for ceramide biosynthesis"Coderch et al., 2003.
Chemical Structure: Sphingoid Base Classes
Phytosphingosine's full chemical name is (2S,3S,4R)-2-amino-1,3,4-octadecanetriol. Its molecular formula is C18H39NO3, with a molecular weight of 305.5 Da. Structurally, it carries three critical features:
- Three hydroxyl groups (OH): at the C1, C3, and C4 positions — one extra OH group compared to sphingosine's two, increasing antimicrobial potential
- A free amine group (NH2): at the C2 position — its capacity for positive charge facilitates binding to negatively charged bacterial membranes
- A saturated C18 chain: no double bond — high chemical stability and resistance to oxidative damage
Skin ceramides are made up of different fatty acids bound to a sphingoid base backbone. Ceramides with a phytosphingosine backbone are classified as ceramide AP (acylphytosphingosine) and ceramide NP (N-acyl-phytosphingosine). These ceramide subtypes are especially concentrated in the outer layers of the stratum corneum and are critical for barrier function.
The Antimicrobial Mechanism: Membrane Disruption
Phytosphingosine's antimicrobial activity occurs through its amine group, which can carry a positive charge at physiological pH. Unlike conventional antibiotics, this mechanism is far more resistant to the development of resistance, because it targets the fundamental physical structure of the bacterial membrane.
The antimicrobial effect proceeds through the following steps:
- Electrostatic binding: the protonated amine group (+) is drawn to the negatively charged membranes of bacterial and fungal cells
- Disruption of membrane integrity: phytosphingosine's hydrophobic chain embeds into the membrane bilayer and disrupts its structure
- Ion leakage: the resulting membrane pores cause potassium, calcium, and other critical ions to leak out
- Cell death: ion imbalance and membrane damage together kill the bacterial or fungal cell
| Microorganism | Phytosphingosine MIC | Clinical Significance | Barrier Connection |
|---|---|---|---|
| Staphylococcus aureus | 1–4 µg/mL | The dominant pathogen in atopic dermatitis; its colonization worsens barrier damage | S. aureus exfoliative toxins break down tight junctions |
| Staphylococcus epidermidis (pathogenic strains) | 2–8 µg/mL | Inflammation in acne and seborrheic dermatitis | Suppresses pathogenic strains while preserving protective flora |
| Candida albicans | 4–16 µg/mL | Seborrheic dermatitis and intertrigo | Fungal infection deepens barrier damage |
| Malassezia furfur | 2–8 µg/mL | Seborrheic dermatitis, dandruff, pityriasis versicolor | Malassezia's lipase activity breaks down ceramides |
| Propionibacterium acnes | 4–16 µg/mL | The inflammatory phase of acne vulgaris | P. acnes's lipase activity disrupts the sebum barrier |
A critical note: while phytosphingosine suppresses pathogenic bacteria, it preserves beneficial flora. Protective strains of S. epidermidis show higher natural resistance to phytosphingosine. This selective antimicrobial activity makes phytosphingosine an ideal component for probiotic-concept skincareIwai et al., 2012.
The Ceramide Precursor Role: The Biosynthesis Pathway
Phytosphingosine's second critical function is serving as a precursor molecule in ceramide biosynthesis. Ceramide production in the stratum corneum occurs via the sphingolipid metabolic pathway, and phytosphingosine sits at the center of this pathway.
The ceramide biosynthesis pathway works as follows:
1. De novo ceramide synthesis: serine + palmitoyl-CoA → sphinganine → dihydrosphingosine → phytosphingosine → ceramide-P (ceramide-AP, ceramide-NP). Phytosphingosine forms ceramide by condensing with a fatty acid via its free amino group.
2. The sphingomyelinase salvage pathway: sphingomyelins in the cell membrane convert into ceramide via the reverse action of sphingomyelin synthase. Phytosphingosine also appears as an intermediate in this pathway.
3. The advantage of topical application: externally applied phytosphingosine penetrates into epidermal keratinocytes and lamellar bodies, increasing endogenous ceramide synthesis. This "precursor therapy" approach complements direct ceramide application and delivers synergistic barrier repair.
Ceramide AP (Acylphytosphingosine)
A ceramide type with a long-chain fatty acid bound to a phytosphingosine backbone. One of the most important fractions of the stratum corneum lipid matrix. The ceramide subtype most notably depleted in atopic dermatitis. Critical for barrier homeostasis and TEWL control. Makes up 30–40% of total ceramides in normal skin.
Ceramide NP (N-acyl-phytosphingosine)
A ceramide type with a normal fatty acid bound to a phytosphingosine backbone. Distributed homogeneously across all layers of the stratum corneum. One of the fundamental building blocks of barrier integrity. CIRÈLL's TriBarrier System includes both ceramide NP and AP, delivering the full spectrum of phytosphingosine-based ceramides.
Atopic Dermatitis and Phytosphingosine Deficiency
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases worldwide. AD's pathogenesis involves a combination of the filaggrin mutation, a Th2-skewed immune response, and barrier dysfunction. In recent years, however, it has become clear that disruptions in sphingolipid metabolism also sit at the center of the diseaseArikawa et al., 2002.
Stratum corneum analysis in atopic dermatitis patients reveals the following findings:
- Total ceramide content is 40–50% lower than in normal skin
- Ceramide AP (phytosphingosine-based) levels are disproportionately low — this specific deficiency points to disrupted phytosphingosine metabolism
- S. aureus colonization reaches 90% (versus 5–30% in normal skin); this bacterium produces toxins that inactivate phytosphingosine
- Sphingosine kinase activity decreases, and phytosphingosine accumulation doesn't occur
- TEWL increases 3–5 fold — directly linked to ceramide deficiency
This connection explains why phytosphingosine supplementation carries strategic importance in atopic dermatitis management: a single molecule both suppresses S. aureus colonization and supplies substrate for ceramide-P (AP/NP) synthesis. It breaks two mutually worsening cycles at once.
A Dual Benefit for Acne-Prone Skin
Acne develops at the intersection of excess sebum, follicular hyperkeratosis, C. acnes colonization, and inflammation. Phytosphingosine intervenes on two critical links of this pathophysiology:
The antimicrobial arm: C. acnes (formerly P. acnes) colonizes sebaceous ducts and produces lipase. This lipase breaks triglycerides down into free fatty acids — irritating, pro-inflammatory molecules. Phytosphingosine shows direct antimicrobial activity against C. acnes, cutting this cascade off at its start.
The barrier-repair arm: contrary to popular belief, acne-prone skin has often already sustained barrier damage. Harsh detergent cleansers, overuse of alcohol-based toners, and peeling treatments weaken the barrier. Phytosphingosine repairs this damage by supporting ceramide synthesis, helping acne-prone skin stay adequately hydrated.
Phytosphingosine's Advantages for Acne
- Direct antimicrobial activity against C. acnes
- Non-comedogenic — doesn't clog pores
- Potential to regulate sebocyte lipid synthesis
- Breaks the irritation cycle through barrier repair
- Supports post-acne barrier recovery
Comparison With Conventional Acne Treatment
Suitable Skin Types and Conditions
Addresses ceramide-AP deficiency and suppresses S. aureus colonization. Its combination with ceramide is the first choice in atopic skin care.
A dual mechanism combining C. acnes inhibition and barrier repair. Ideal for barrier-compromised acne-prone skin — non-comedogenic.
Reduces sensitive skin reactivity through anti-inflammatory and antimicrobial protection. Should be combined with fragrance-free, non-irritating formulas.
Carries mechanisms that may contribute to sebum balance. Preferred in light gel or lotion formulations.
As a ceramide precursor, it accelerates barrier repair. Can be used in post-procedure and post-laser care.
Antimicrobial activity against Malassezia furfur. An active also used in scalp products, supporting dandruff and seborrheic dermatitis management.
The Importance of the Ceramide Combination
While phytosphingosine is a powerful active on its own, its true potential emerges in combination with ceramides. This combination achieves barrier restoration through two simultaneous mechanisms:
Exogenous ceramide (from outside): ceramides that integrate directly into the stratum corneum lipid matrix instantly fill damaged barrier gaps. This effect is fast (within hours) and immediately reduces TEWL. CIRÈLL's Biomimetic TriBarrier System — ceramide NP, AP, and EOP — handles this function.
Endogenous ceramide synthesis (from within): phytosphingosine works as a substrate for ceramide biosynthesis inside the keratinocyte. This effect is slower (days to weeks) but longer-lasting, because it increases skin's own ceramide-production capacity.
Combining both approaches delivers immediate TEWL protection together with a long-term increase in barrier capacity. The phytosphingosine + ceramide combination produces far superior clinical results than either ceramide alone or phytosphingosine aloneCoderch et al., 2003.
A Concentration and Efficacy Table
| Concentration Range | Primary Effect | Product Type | Target Indication |
|---|---|---|---|
| 0.001–0.01% (1–10 ppm) | The onset of antimicrobial effect | Toner, serum, lotion | Protective, preventive care |
| 0.01–0.1% | Noticeable antimicrobial effect + mild ceramide support | Serum, cream | Acne-prone, sensitive skin |
| 0.1–0.5% | Strong antimicrobial effect + active ceramide precursor function | Rich cream, medical cosmetics | Atopic dermatitis, severe barrier damage |
| 0.5%+ | Maximum antimicrobial effect; irritation risk to watch | Pharmaceutical/medical products | Under dermatological supervision |
An important note: at higher concentrations (>0.5%), phytosphingosine carries a mild irritation potential. A gradual-increase strategy is recommended for sensitive skin. Formulation pH should be kept between 4.0–5.5 — this range optimizes both antimicrobial activity and the ceramide-precursor function.
A Daily Usage Protocol
pH-Friendly Cleansing: preserving the acid mantle (pH 4.5–5.5) is essential for phytosphingosine and ceramides to function. High-pH soaps and heavily foaming cleansers disrupt this balance. Choose a fragrance-free, pH-balanced micellar water or a light gel cleanser.
A Phytosphingosine-Containing Toner or Serum: apply to clean, slightly damp skin. Products with phytosphingosine content, typically in the 0.01–0.1% range, are formulated as a toner or a light serum. Apply by gently patting skin; rubbing causes barrier stress.
A Ceramide-Based Moisturizer (TriBarrier support): apply a moisturizer containing ceramide NP+AP+EOP over the phytosphingosine serum. This layer reinforces the endogenous ceramide synthesis supported by phytosphingosine with exogenous ceramide supplementation. Together, the two provide both immediate and long-term barrier protection.
Morning Routine — SPF Is Mandatory: UV radiation disrupts sphingolipid metabolism and reverses phytosphingosine's gains. A mineral-filter (zinc oxide/titanium dioxide) SPF 50+ is mandatory every morning. Oil-free, non-comedogenic formulations should be preferred for atopic or acne-prone skin.
Intensive Evening Care: support the skin's overnight renewal cycle with an evening application of a phytosphingosine-rich cream or balm. As TEWL rises at night, intensive barrier supplementation minimizes this loss. In atopic skin, the wet-wrap technique can increase phytosphingosine absorption.
Assessment (4–8 Weeks): the antimicrobial effect (reduced acne, decreased reactivity) can be observed within 2–4 weeks. Increased ceramide synthesis and TEWL improvement require 4–8 weeks. In atopic dermatitis follow-up, SCORAD and itch-score measurements provide objective assessment.
Conclusion: Phytosphingosine in CIRÈLL's TriBarrier
Phytosphingosine offers a rare dual competency among cosmetic actives: both active antimicrobial defense and structural barrier construction. It stands out as a strategic active across every condition where microbiotic imbalance deepens barrier damage — atopic dermatitis, acne, seborrheic dermatitis, and sensitive skin foremost among them.
CIRÈLL's TriBarrier System formulates phytosphingosine together with ceramide NP, AP, and EOP to maximize this dual competency. The biomimetic design principle: phytosphingosine, which supports endogenous ceramide synthesis (a precursor) + ceramides that directly repair the barrier (a building block) + antimicrobial protection, come together within a single formulation. In sensitive, atopic, or microbiotically imbalanced skin, CIRÈLL targets long-term barrier health through this comprehensive approach.
Frequently Asked Questions
What is phytosphingosine, and what does it do?
Phytosphingosine is a sphingoid base naturally present in human skin. It serves both as a powerful antimicrobial agent (inhibiting S. aureus, C. acnes, and Candida) and as a precursor in ceramide biosynthesis. This dual role makes it an ideal active for barrier repair and antimicrobial defense.
How does phytosphingosine help with atopic dermatitis?
In atopic dermatitis, ceramide-AP (phytosphingosine-based) deficiency and S. aureus colonization form two intertwined problems. Phytosphingosine both supports ceramide-AP synthesis and suppresses S. aureus — breaking both cycles at once.
Is phytosphingosine suitable for acne-prone skin?
Yes. With its antimicrobial activity against C. acnes and its non-comedogenic structure, it's ideal for acne-prone skin. Its barrier-repair effect offsets the barrier damage caused by aggressive acne treatments (BHA, retinoids).
Can phytosphingosine be used together with ceramide?
Absolutely — this combination is ideal. Ceramide provides exogenous barrier supplementation while phytosphingosine supports endogenous ceramide synthesis. Immediate and long-term barrier protection are achieved simultaneously.
Is phytosphingosine suitable for oily skin?
Yes. Phytosphingosine is a non-comedogenic active that doesn't increase sebum production. It can be safely used in light serum or gel formulations for oily skin as well.
Is phytosphingosine safe for sensitive skin?
At low concentrations (0.01–0.1%), its safety profile is very good. At higher concentrations (>0.5%), it carries a mild irritation potential. A gradual increase starting from a low concentration is recommended for sensitive skin.
Does phytosphingosine carry a risk of antimicrobial resistance?
Unlike conventional antibiotics, phytosphingosine targets the membrane's physical structure. Developing resistance against this mechanism is extremely difficult. It can be preferred in situations that don't require topical antibiotic treatment.
What is the difference between phytosphingosine and sphingosine?
Sphingosine (d18:1) contains two OH groups and one double bond. Phytosphingosine (t18:0) carries three OH groups and a saturated chain. This difference gives phytosphingosine stronger antimicrobial activity and higher chemical stability.
Is phytosphingosine effective for seborrheic dermatitis?
Yes. Its antimicrobial activity against Malassezia furfur supports seborrheic dermatitis and dandruff management. It's also an active effectively used in scalp products.
Which ceramide subtypes does phytosphingosine precede?
It primarily precedes synthesis of ceramide AP (acylphytosphingosine) and ceramide NP (N-acyl-phytosphingosine). These two ceramide subtypes are critical fractions of the stratum corneum lipid matrix — the ceramide types most notably depleted in atopic dermatitis.
What concentration of phytosphingosine should products contain?
0.001–0.01% is recommended for protective care, 0.01–0.1% for active care, and 0.1–0.5% for intensive repair. Sensitive skin should start with a low concentration.
Is phytosphingosine suitable for rosacea?
Given its sensitive-skin-barrier-supporting and anti-inflammatory effects, it can be used as a supporting active in rosacea care. However, dosage and formulation should be chosen carefully; irritation risk should be assessed at higher concentrations.
Is phytosphingosine safe during pregnancy?
Systemic absorption via topical application is minimal, and its overall safety profile is favorable. Consulting a dermatologist for any new active during pregnancy is good practice.
Does the phytosphingosine and niacinamide combination work well?
Yes. Niacinamide is an active that increases ceramide synthesis (ceramide NP) and provides sebum control. Its combination with phytosphingosine addresses barrier support, antimicrobial defense, and sebum management all at once.
How long does phytosphingosine take to show effect?
The antimicrobial effect (reduced acne or reactivity) can be observed within 2–4 weeks. Increased ceramide synthesis and TEWL improvement require 4–8 weeks. Regular use is essential.
Scientific Sources
- Coderch L, Lopez O, de la Maza A, Parra JL. Ceramides and skin function. Am J Clin Dermatol. 2003;4(2):107–129. PMID: 12553851
- Iwai I, Han H, den Hollander L, et al. The human skin barrier is organized as stacked bilayers of fully extended ceramides with cholesterol molecules associated with the ceramide sphingoid moiety. J Invest Dermatol. 2012;132(9):2215–2225. PMID: 22158558
- Arikawa J, Ishibashi M, Kawashima M, et al. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol. 2002;119(2):433–439. PMID: 12190865
- Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol. 2005;125(2):183–200. PMID: 16098026
- Meckfessel MH, Brandt S. The structure, function, and importance of ceramides in skin. J Am Acad Dermatol. 2014;71(1):177–184. PMID: 24656726
- Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17(12):1063–1072. PMID: 19043850
- Schade H, Marchionini A. Der Säuremantel der Haut (nach Gaskettenmessungen). Klin Wochenschr. 1928;7:12–14.
- Fluhr JW, Darlenski R, Surber C. Glycerol and the skin: holistic approach to its origin and functions. Br J Dermatol. 2008;159(1):23–34. PMID: 18510666
- Rawlings AV, Harding CR. Moisturization and skin barrier function. Dermatol Ther. 2004;17(Suppl 1):43–48. PMID: 14728698
- Bouwstra JA, Ponec M. The skin barrier in healthy and diseased state. Biochim Biophys Acta. 2006;1758(12):2080–2095. PMID: 16945325
CIRÈLL's Choice of Phytosphingosine: Protect, Balance, Renew
Within the CIRÈLL formulation, phytosphingosine takes on a dual role through its anti-inflammatory and ceramide-precursor properties. Like a biological key — once it turns the right lock, the lamellar lipid production chain begins.
- A ceramide synthesis precursor: converted into ceramide in the body by the ceramide synthase (CerS) enzyme — feeding the barrier's structural renewal.
- Antimicrobial against Staph aureus: curbs Staph overgrowth in atopic and eczema-prone skin.
- NF-κB inhibition: creates a layered effect on the inflammatory cascade through synergy with madecassoside.
- Microbiota selectivity: minimal effect on beneficial organisms, selective activity against pathogens.
At CIRÈLL, phytosphingosine isn't just an antimicrobial — it's a "constructive protector" active that supports the ceramide-production chain.